165 related articles for article (PubMed ID: 24289584)
21. Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.
Chen JH; Xiang JY; Ding GP; Cao LP
J Zhejiang Univ Sci B; 2016 Jul; 17(7):537-44. PubMed ID: 27381730
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
Hu L; Cao D; Li Y; He Y; Guo K
Cancer Biol Ther; 2012 May; 13(7):516-26. PubMed ID: 22406996
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
[TBL] [Abstract][Full Text] [Related]
24. Effects of total flavonoids of sea buckthorn ( Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells.
Hou D; Wang D; Ma X; Chen W; Guo S; Guan H
Int J Immunopathol Pharmacol; 2017 Dec; 30(4):353-361. PubMed ID: 28994628
[TBL] [Abstract][Full Text] [Related]
25. Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells.
Zhao JJ; Pan K; Wang QJ; Xu ZD; Weng DS; Li JJ; Li YQ; Xia JC
Chin J Cancer; 2013 Oct; 32(10):553-60. PubMed ID: 23470144
[TBL] [Abstract][Full Text] [Related]
26. Augmented CD3(+)CD8(+) and CD3(+)CD56(-) cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor.
Wang L; Yi Y; Yin D; Zhou Z; Fan J; Ye W; Zhao W
Cytotherapy; 2016 Apr; 18(4):581-9. PubMed ID: 26971686
[TBL] [Abstract][Full Text] [Related]
27. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
29. Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.
Durrieu L; Lemieux W; Dieng MM; Fontaine F; Duval M; Le Deist F; Haddad E
Cytotherapy; 2014 Jun; 16(6):845-56. PubMed ID: 24529554
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
[TBL] [Abstract][Full Text] [Related]
31. Xanthan gum enhances peripheral blood CIK cells cytotoxicity in serum-free medium.
Huang H; Gong Z; Zhu X; Tan WS; Cai H
Biotechnol Prog; 2022 Sep; 38(5):e3279. PubMed ID: 35661450
[TBL] [Abstract][Full Text] [Related]
32. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
Zhu BQ; Ju SW; Shu YQ
Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
[TBL] [Abstract][Full Text] [Related]
33. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
34. [Effects of different stimulatory factors on functions of CIK cells].
Liu JQ; Zhu Y; Chen FX; Zhou Y; Ji HC; Yang WY; Lyu XT; Zhang S; Tao ZZ; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1021-6. PubMed ID: 23998605
[TBL] [Abstract][Full Text] [Related]
35. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
36. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
37. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells.
Kim YJ; Lim J; Kang JS; Kim HM; Lee HK; Ryu HS; Kim JY; Hong JT; Kim Y; Han SB
Arch Pharm Res; 2010 Nov; 33(11):1789-95. PubMed ID: 21116782
[TBL] [Abstract][Full Text] [Related]
38. Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells.
Ma C; Wei Y; Liu Q; Xin Y; Cao G; Wang X; Yang P
Biomed Pharmacother; 2019 Sep; 117():109167. PubMed ID: 31387180
[TBL] [Abstract][Full Text] [Related]
39. Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells.
Laurin D; Marin V; Biagi E; Pizzitola I; Agostoni V; Gallot G; Vié H; Jacob MC; Chaperot L; Aspord C; Plumas J
J Biomed Biotechnol; 2010; 2010():234540. PubMed ID: 20617141
[TBL] [Abstract][Full Text] [Related]
40. Altered effector function of peripheral cytotoxic cells in COPD.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]